Evidence map›Paper›PMID 28034921›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Matrix stiffening promotes a tumor vasculature phenotype.

Francois Bordeleau, Brooke N Mason, Emmanuel Macklin Lollis, Michael Mazzola, Matthew R Zanotelli, Sahana Somasegar, Joseph P Califano, Christine Montague, Danielle J LaValley, John Huynh and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 241 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
241citing papers in PubMed, 1 pooled it
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

241 citing papers in PubMed, 1 synthesis or guideline pooled it, 392 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Beyond DNA damage: 3D tumor models and the integrin mechanobiology of radioresistance.Journal of experimental & clinical cancer research : CR · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

181 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Francois BordeleauNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853.
Brooke N MasonNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853.
Emmanuel Macklin LollisRobert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853.
Michael MazzolaNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853.
Matthew R ZanotelliNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853.
Sahana SomasegarNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853.
Joseph P CalifanoNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853.
Christine MontagueNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853.
Danielle J LaValleyNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853.
John HuynhNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853.
Nuria Mencia-TrinchantDivision of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY 10065.
Yashira L Negrón AbrilBiomedical Sciences, Cornell University, Ithaca, NY 14853.
Duane C HassaneDivision of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY 10065.
Lawrence J BonassarNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853.
Jonathan T ButcherNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853.
Robert S WeissBiomedical Sciences, Cornell University, Ithaca, NY 14853.
Cynthia A Reinhart-KingNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853; cak57@cornell.edu.
Cornell University · US

Funding

CHEMISTRY OF BIOLOGICAL SYSTEMST32GM008500 · NIGMS · CORNELL UNIVERSITY ITHACA · PI LIN, HENING · 1996 to 2020
$5.4M
Succinylation and Malonylation as Novel Protein Modifications in CancerR01CA163255 · NCI · CORNELL UNIVERSITY · PI CERIONE, RICHARD A., LIN, HENING · 2011 to 2015
$2.9M
Mechanical Regulation of Tumor AngiogenesisR01HL127499 · NHLBI · VANDERBILT UNIVERSITY · PI REINHART-KING, CYNTHIA A. · 2015 to 2019
$2.4M
Broad wavelength range Zeiss 780 NLO/confocal system for the Cornell Imaging CoreS10OD018516 · OD · CORNELL UNIVERSITY · PI ZIPFEL, WARREN R · 2014 to 2014
$834k
Acquisition of a VisualSonics Vevo 2100 mouse ultrasound for Cornell Imaging faciS10OD016191 · OD · CORNELL UNIVERSITY · PI WILLIAMS, REBECCA M · 2014 to 2014
$534k
NCI NIH HHS R01 CA163255NHLBI NIH HHS R01 HL127499NIGMS NIH HHS T32 GM008500NIH HHS S10 OD016191NIH HHS S10 OD018516
6 · The paper itself

Abstract

Tumor microvasculature tends to be malformed, more permeable, and more tortuous than vessels in healthy tissue, effects that have been largely attributed to up-regulated VEGF expression. However, tumor tissue tends to stiffen during solid tumor progression, and tissue stiffness is known to alter cell behaviors including proliferation, migration, and cell-cell adhesion, which are all requisite for angiogenesis. Using in vitro, in vivo, and ex ovo models, we investigated the effects of matrix stiffness on vessel growth and integrity during angiogenesis. Our data indicate that angiogenic outgrowth, invasion, and neovessel branching increase with matrix cross-linking. These effects are caused by increased matrix stiffness independent of matrix density, because increased matrix density results in decreased angiogenesis. Notably, matrix stiffness up-regulates matrix metalloproteinase (MMP) activity, and inhibiting MMPs significantly reduces angiogenic outgrowth in stiffer cross-linked gels. To investigate the functional significance of altered endothelial cell behavior in response to matrix stiffness, we measured endothelial cell barrier function on substrates mimicking the stiffness of healthy and tumor tissue. Our data indicate that barrier function is impaired and the localization of vascular endothelial cadherin is altered as function of matrix stiffness. These results demonstrate that matrix stiffness, separately from matrix density, can alter vascular growth and integrity, mimicking the changes that exist in tumor vasculature. These data suggest that therapeutically targeting tumor stiffness or the endothelial cell response to tumor stiffening may help restore vessel structure, minimize metastasis, and aid in drug delivery.

Indexed as

AnimalsBiomechanical PhenomenaCattleCells, CulturedChick EmbryoCollagenExtracellular MatrixFemaleHumansHuman Umbilical Vein Endothelial CellsMammary Neoplasms, ExperimentalMatrix MetalloproteinasesMiceMicrovesselsNeoplasm InvasivenessNeovascularization, PathologicCollagenMatrix Metalloproteinasesendothelial cellsextracellular matrixglycationtumor stiffnessvascular permeability

Identifiers

PMID28034921
PMCPMC5255592
OpenAlexW2565401689

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.